{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T02:32:23Z","timestamp":1768789943662,"version":"3.49.0"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.yebeh.2021.107797","type":"journal-article","created":{"date-parts":[[2021,2,7]],"date-time":"2021-02-07T00:43:54Z","timestamp":1612658634000},"page":"107797","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Vortioxetine increases absence-like seizures in WAG\/Rij rats but decreases penicillin- and pentylenetetrazole-induced seizures in Wistar rats"],"prefix":"10.1016","volume":"116","author":[{"given":"Hatice","family":"Aygun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6594-3080","authenticated-orcid":false,"given":"Mustafa","family":"Ayyildiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"37","key":"10.1016\/j.yebeh.2021.107797_b0005","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.yebeh.2014.05.031","article-title":"The consequences of refractory epilepsy and its treatment","volume":"2014","author":"Laxer","year":"2014","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2021.107797_b0010","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.yebeh.2016.07.013","article-title":"Epilepsy or seizure disorder? The effect of cultural and socioeconomic factors on self-reported prevalence","volume":"62","author":"Kroner","year":"2016","journal-title":"Epilepsy Behav"},{"issue":"4","key":"10.1016\/j.yebeh.2021.107797_b0015","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.yebeh.2007.12.019","article-title":"The global burden and stigma of epilepsy","volume":"12","author":"De Boer","year":"2008","journal-title":"Epilepsy Behav"},{"issue":"12","key":"10.1016\/j.yebeh.2021.107797_b0020","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1111\/j.1528-1167.2007.01222.x","article-title":"Psychiatric comorbidity in epilepsy: a population-based analysis","volume":"48","author":"Tellez-Zenteno","year":"2007","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.yebeh.2021.107797_b0025","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.mayocp.2016.12.012","article-title":"Association between selective serotonin-reuptake inhibitor antidepressants and increased risk of poststroke epilepsy","volume":"92","author":"Kanner","year":"2017","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.yebeh.2021.107797_b0030","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1528-1157.1996.tb00006.x","article-title":"The clinical course of epilepsy and its psychosocial correlates: findings from a U.K. Community study","volume":"37","author":"Jacoby","year":"1996","journal-title":"Epilepsia"},{"issue":"Suppl 2","key":"10.1016\/j.yebeh.2021.107797_b0035","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.0013-9580.2004.452005.x","article-title":"Depression in epilepsy: ignoring clinical expression of neuronal network dysfunction?","volume":"45","author":"Gilliam","year":"2004","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2021.107797_b0040","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1192\/bjp.170.3.205","article-title":"Suicide as an outcome for mental disorders. A meta-analysis","volume":"170","author":"Harris","year":"1997","journal-title":"Br J Psychiatry"},{"issue":"8","key":"10.1016\/j.yebeh.2021.107797_b0045","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1111\/j.1528-1167.2009.02106.x","article-title":"Suicide in people with epilepsy: how great is the risk?","volume":"50","author":"Bell","year":"2009","journal-title":"Epilepsia"},{"issue":"8","key":"10.1016\/j.yebeh.2021.107797_b0050","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S1474-4422(07)70175-8","article-title":"Epilepsy and risk of suicide: a population-based case-control study","volume":"6","author":"Christensen","year":"2007","journal-title":"Lancet Neurol"},{"issue":"2","key":"10.1016\/j.yebeh.2021.107797_b0055","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/S0014-4886(03)00352-2","article-title":"5-HT2C receptors inhibit and 5-HT1A receptors activate the generation of spike\u2013wave discharges in a genetic rat model of absence epilepsy","volume":"184","author":"Jakus","year":"2003","journal-title":"Exp Neurol"},{"issue":"2","key":"10.1016\/j.yebeh.2021.107797_b0060","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.neulet.2006.06.014","article-title":"Effect of gabaergic, glutamatergic, antipsychotic and antidepressant drugs on pilocarpine-induced seizures and status epilepticus","volume":"408","author":"Freitas","year":"2006","journal-title":"Neurosci Lett"},{"issue":"2","key":"10.1016\/j.yebeh.2021.107797_b0065","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.psc.2013.02.004","article-title":"Antidepressant overdose-induced seizures","volume":"36","author":"Judge","year":"2013","journal-title":"Psychiatr Clin North Am"},{"issue":"63","key":"10.1016\/j.yebeh.2021.107797_b0070","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.nbd.2013.11.020","article-title":"Chronic antidepressant treatment accelerates kindling epileptogenesis in rats","volume":"2014","author":"Cardamone","year":"2014","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.yebeh.2021.107797_b0075","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.yebeh.2019.03.050","article-title":"The effect of fluoxetine on penicillin-induced epileptiform activity","volume":"95","author":"Aygun","year":"2019","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2021.107797_b0080","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.biopsych.2006.09.023","article-title":"Seizure incidence in psychopharmacological clinical trials: an analysis of Food and Drug Administration (FDA) summary basis of approval reports","volume":"62","author":"Alper","year":"2007","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.yebeh.2021.107797_b0085","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2165\/00002018-200225020-00004","article-title":"Effects of psychotropic drugs on seizure threshold","volume":"25","author":"Pisani","year":"2002","journal-title":"Drug Saf"},{"key":"10.1016\/j.yebeh.2021.107797_b0090","first-page":"617","article-title":"Adverse effects of antipsychotic medications","volume":"81","author":"Muench","year":"2010","journal-title":"Am Fam Physician"},{"issue":"2","key":"10.1016\/j.yebeh.2021.107797_b0095","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nrneurol.2015.243","article-title":"Management of psychiatric and neurological comorbidities in epilepsy","volume":"12","author":"Kanner","year":"2016","journal-title":"Nat Rev Neurol"},{"issue":"9Pt 1","key":"10.1016\/j.yebeh.2021.107797_b0100","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1212\/WNL.28.9.953","article-title":"Imipramine in absence and myoclonic-astatic seizures","volume":"28","author":"Fromm","year":"1978","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.yebeh.2021.107797_b0105","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1212\/WNL.45.10.1926","article-title":"The anticonvulsant effect of fluoxetine in humans","volume":"45","author":"Favale","year":"1995","journal-title":"Neurology"},{"issue":"Suppl 1","key":"10.1016\/j.yebeh.2021.107797_b0110","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1528-1167.2010.02908.x","article-title":"The serotonin axis: shared mechanisms in seizures, depression, and SUDEP","volume":"52","author":"Richerson","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2021.107797_b0115","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.pharmthera.2014.07.001","article-title":"Vortioxetine, a novel antidepressant with multimodal activity: review of preclinical and clinical data","volume":"145C","author":"Saanchez","year":"2015","journal-title":"Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.yebeh.2021.107797_b0120","doi-asserted-by":"crossref","first-page":"88","DOI":"10.4103\/aian.AIAN_291_17","article-title":"Recovery of visual scotomas by vortioxetine in a patient with symptomatic occipital lobe epilepsy","volume":"21","author":"Onder","year":"2018","journal-title":"Ann Indian Academy Neurol"},{"issue":"6","key":"10.1016\/j.yebeh.2021.107797_b0125","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1590\/0004-282x20190064","article-title":"The effect of vortioxetine on penicillin-induced epileptiform activity in rats","volume":"77","author":"\u00d6g\u00fcn","year":"2019","journal-title":"Arq Neuropsiquiatr"},{"key":"10.1016\/j.yebeh.2021.107797_b0130","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/epi.13670","article-title":"Operational classification of seizure types by the International League Against Epilepsy: Position Paper of the ILAE Commission for Classification and Terminology","volume":"58","author":"Fisher","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2021.107797_b0135","first-page":"309","article-title":"Seizures and epilepsy","volume":"103","author":"Johnson","year":"2019","journal-title":"Med Clin"},{"key":"10.1016\/j.yebeh.2021.107797_b0140","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a022426","article-title":"Seizures and epilepsy: an overview for neuroscientists","volume":"5","author":"Stafstrom","year":"2015","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.yebeh.2021.107797_b0145","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0165-0173(89)90003-9","article-title":"Animal models of the epilepsies","volume":"14","author":"Fisher","year":"1989","journal-title":"Brain Res Rev"},{"issue":"7","key":"10.1016\/j.yebeh.2021.107797_b0150","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1111\/j.1528-1167.2009.02098.x","article-title":"The effects of intracerebroventricular AM-251, a CB1-receptor antagonist, and ACEA, a CB1-receptor agonist, on penicillin-induced epileptiform activity in rats","volume":"50","author":"Kozan","year":"2009","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.yebeh.2021.107797_b0155","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.brs.2014.10.017","article-title":"Effect of subthalamic nucleus stimulation on penicillin induced focal motor seizures in primate","volume":"8","author":"Prabhu","year":"2015","journal-title":"Brain Stimul"},{"key":"10.1016\/j.yebeh.2021.107797_b0160","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/0024-3205(90)90334-N","article-title":"Excitatory amino acid antagonists and pentylenetetrazol-induced seizures during ontogenesis: I. The effects of 2-amino7-phosphonoheptanoate","volume":"46","author":"Velisek","year":"1990","journal-title":"Life Sci"},{"key":"10.1016\/j.yebeh.2021.107797_b0165","first-page":"37","article-title":"Epilepsinin deneysel modelleri","volume":"4","author":"Onat","year":"2008","journal-title":"Epilepsi. Nobel T\u0131p Kitabevleri."},{"key":"10.1016\/j.yebeh.2021.107797_b0170","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0920-1211(92)90029-S","article-title":"Genetic models of absence epilepsy, with emphasis on the WAG\/Rij strain of rats","volume":"12","author":"Coenen","year":"1992","journal-title":"Epilepsy Res"},{"issue":"1","key":"10.1016\/j.yebeh.2021.107797_b0175","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s00221-006-0425-7","article-title":"The effects of vitamin E on penicillin-induced epileptiform activity in rats","volume":"174","author":"Ayyildiz","year":"2006","journal-title":"Exp Brain Res"},{"key":"10.1016\/j.yebeh.2021.107797_b0180","series-title":"The rat brain in stereotaxic coordinates: hard cover edition","author":"Paxinos","year":"2006"},{"issue":"10","key":"10.1016\/j.yebeh.2021.107797_b0185","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1177\/0960327113520017","article-title":"The protective effects of endothelin-A receptor antagonist BQ-123 in pentylenetetrazole-induced seizure in rats","volume":"33","author":"Erdogan","year":"2014","journal-title":"Human Exp Toxicol"},{"key":"10.1016\/j.yebeh.2021.107797_b0190","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.1021\/jm101459g","article-title":"Discovery of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): a novel multimodal compound for the treatment of major depressive disorder","volume":"54","author":"Bang-Andersen","year":"2011","journal-title":"J Med Chem"},{"key":"10.1016\/j.yebeh.2021.107797_b0195","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.neuropharm.2013.05.014","article-title":"Antidepressant and anxiolytic potential of the multimodal antidepressant vortioxetine (Lu AA21004) assessed by behavioural and neurogenesis outcomes in mice","volume":"73","author":"Guilloux","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.yebeh.2021.107797_b0200","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1016\/j.euroneuro.2013.01.002","article-title":"5-HTT and 5-HT(1A) receptor occupancy of the novel substance vortioxetine (Lu AA21004). A PET study in control subjects","volume":"23","author":"Stenkrona","year":"2013","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.yebeh.2021.107797_b0205","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1517\/17425255.2014.904286","article-title":"Pharmacokinetic evaluation of vortioxetine for the treatment of major depressive disorder","volume":"10","author":"Dubovsky","year":"2014","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.yebeh.2021.107797_b0210","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0026-895X(25)13464-0","article-title":"Gamma-aminobutyric acid receptor binding in mammalian brain. Heterogeneity of binding sites","volume":"19","author":"Olsen","year":"1981","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.yebeh.2021.107797_b0215","series-title":"Models of seizures and epilepsy","first-page":"127","article-title":"Models of chemically-induced acute seizures","author":"Velisek","year":"2006"},{"key":"10.1016\/j.yebeh.2021.107797_b0220","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.yebeh.2011.07.002","article-title":"The interaction of melatonin and agmatine on pentylenetetrazole-induced seizure threshold in mice","volume":"22","author":"Moezi","year":"2011","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2021.107797_b0225","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/0013-4694(83)90028-7","article-title":"Penicillin-induced epileptic foci in the motor cortex: Vertical inhibition","volume":"56","author":"Elger","year":"1983","journal-title":"Electroencephalogr Clin Neuro-physiol"},{"key":"10.1016\/j.yebeh.2021.107797_b0230","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.neuropharm.2014.05.005","article-title":"Head-to head comparison of mGlu1 and mGlu5 receptor activation in chronic treatment of absence epilepsy in WAG\/Rij rats","volume":"85","author":"D'Amore","year":"2014","journal-title":"Neuropharmacol"},{"issue":"2","key":"10.1016\/j.yebeh.2021.107797_b0235","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1017\/S1092852915000486","article-title":"Regional distribution of serotonergic receptors: a systems neuroscience perspective on the downstream effects of the multimodal-acting antidepressant vortioxetine on excitatory and inhibitory neurotransmission","volume":"21","author":"Pehrson","year":"2016","journal-title":"CNS Spectr"},{"key":"10.1016\/j.yebeh.2021.107797_b0240","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0893-133X(96)00242-4","article-title":"Selective activation of postsynaptic 5-HT1A receptors induces rapid antidepressant response","volume":"16","author":"Blier","year":"1997","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.yebeh.2021.107797_b0245","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0006-3223(02)01643-8","article-title":"Is there a role for 5-HT1A agonists in the treatment of depression?","volume":"53","author":"Blier","year":"2003","journal-title":"Biol Psychiatry"},{"issue":"2","key":"10.1016\/j.yebeh.2021.107797_b0250","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s00221-013-3757-0","article-title":"The role of different serotonin receptor subtypes in seizure susceptibility","volume":"232","author":"Gharedaghi","year":"2014","journal-title":"Exp Brain Res"},{"key":"10.1016\/j.yebeh.2021.107797_b0255","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.lfs.2018.09.007","article-title":"The role of serotonin and its receptors on the anticonvulsant effect of curcumin in pentylenetetrazol-induced seizures","volume":"211","author":"Jahan","year":"2018","journal-title":"Life Sci"},{"issue":"3","key":"10.1016\/j.yebeh.2021.107797_b0260","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.neuropharm.2005.03.020","article-title":"5-HT 1A receptor agonists modify epileptic seizures in three experimental models in rats","volume":"49","author":"L\u00f3pez-Meraz","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.yebeh.2021.107797_b0265","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1073\/pnas.97.26.14731","article-title":"Impaired hippocampal-dependent learning and functional abnormalities in the hippocampus in mice lacking serotonin 1A receptors","volume":"97","author":"Sarnyai","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.yebeh.2021.107797_b0270","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0006-8993(98)00801-4","article-title":"The 5-HT1A agonist 8-OH-DPAT increases the number of spike-wave discharges in a genetic rat model of absence epilepsy","volume":"807","author":"Gerber","year":"1998","journal-title":"Brain Res"},{"key":"10.1016\/j.yebeh.2021.107797_b0275","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0304-3940(99)00015-4","article-title":"A serotonin-1A receptor agonist and N-methyl-D-aspartate receptor antagonist oppose each other\u2019s effects in a genetic rat epilepsy model","volume":"261","author":"Filakovszky","year":"1999","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.yebeh.2021.107797_b0280","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0197-0186(00)00120-0","article-title":"8-OH-DPAT and MK-801 affect epileptic activity independently of vigilance","volume":"38","author":"Filakovszky","year":"2001","journal-title":"Neurochem Int"},{"issue":"1","key":"10.1016\/j.yebeh.2021.107797_b0285","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.neulet.2004.01.072","article-title":"Selective 5-HT 1A and 5-HT 7 antagonists decrease epileptic activity in the WAG\/Rij rat model of absence epilepsy","volume":"359","author":"Graf","year":"2004","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.yebeh.2021.107797_b0290","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1111\/j.1471-4159.2006.04277.x","article-title":"Serotonin and epilepsy","volume":"100","author":"Bagdy","year":"2007","journal-title":"J Neurochem"},{"key":"10.1016\/j.yebeh.2021.107797_b0295","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1038\/sj.bjp.0703510","article-title":"Serotonin inhibition of the NMDA receptor\/nitric oxide\/cyclic GMP pathway in human neocortex slices: involvement of 5-HT(2C) and 5- HT(1A) receptors","volume":"130","author":"Maura","year":"2000","journal-title":"Br J Pharmacol"},{"issue":"4","key":"10.1016\/j.yebeh.2021.107797_b0300","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1152\/jn.00650.2001","article-title":"Neuromodulatory role of serotonin in the ferret thalamus","volume":"87","author":"Monckton","year":"2002","journal-title":"J Neurophysiol"},{"issue":"3","key":"10.1016\/j.yebeh.2021.107797_b0305","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1017\/S1472928803000220","article-title":"Comparative physiological and serotoninergic properties of pulvinar neurons in the monkey, cat and ferret","volume":"2","author":"Monckton","year":"2003","journal-title":"Thalamus Relat Syst"},{"issue":"1","key":"10.1016\/j.yebeh.2021.107797_b0310","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.seizure.2009.10.006","article-title":"Seizure susceptibility alteration through 5-HT(3) receptor: modulation by nitric oxide","volume":"19","author":"Gholipour","year":"2010","journal-title":"Seizure"},{"issue":"1","key":"10.1016\/j.yebeh.2021.107797_b0315","first-page":"29","article-title":"5-HT3 Receptors: a potential therapeutic target for epilepsy","volume":"16","author":"Zhao","year":"2018","journal-title":"Curr Neuropharmacol"},{"key":"10.1016\/j.yebeh.2021.107797_b0320","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ejphar.2012.04.011","article-title":"Involvement of 5-HT 7 receptors in the pathogenesis of temporal lobe epilepsy","volume":"685","author":"Yang","year":"2012","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.yebeh.2021.107797_b0325","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0028-3908(01)00149-6","article-title":"5-HT 7 receptors modulate synchronized network activity in rat hippocampus","volume":"42","author":"Gill","year":"2002","journal-title":"Neuropharmacol"},{"key":"10.1016\/j.yebeh.2021.107797_b0330","doi-asserted-by":"crossref","first-page":"526","DOI":"10.4103\/1673-5374.130083","article-title":"Increased expression of Notch1 in temporal lobe epilepsy: animal models and clinical evidence","volume":"9","author":"Liu","year":"2014","journal-title":"Neural Regen Res"},{"key":"10.1016\/j.yebeh.2021.107797_b0335","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/0165-6147(92)90119-Q","article-title":"Recent advances in the electrophysiological characterization of 5-HT3 receptors","volume":"13","author":"Peters","year":"1992","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.yebeh.2021.107797_b0340","first-page":"229","article-title":"Cellular distribution of 5-HT7 receptor mRNA in rat brain","volume":"123","author":"Stowe","year":"1998","journal-title":"Br J Pharmacol"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505021000317?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505021000317?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:39:27Z","timestamp":1761503967000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505021000317"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":68,"alternative-id":["S1525505021000317"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2021.107797","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vortioxetine increases absence-like seizures in WAG\/Rij rats but decreases penicillin- and pentylenetetrazole-induced seizures in Wistar rats","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2021.107797","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107797"}}